Publications

Find out how to correctly dispose of security sensitive biological agents (SSBAs).

This fact sheet outlines the information security requirements of the SSBA Regulatory Scheme, and helps entities and facilities to meet these requirements under the SSBA Standards.

This fact sheet provides an overview of the extra requirements for handling Tier 1 SSBAs if you are already registered for handling Tier 2 SSBAs.

This fact sheet gives an overview of domestic legislation that may have affect entities handling security sensitive biological agents (SSBAs).

This fact sheets gives an overview of international conventions that may have implications for entities handling security sensitive biological agents (SSBAs).

Learn about security sensitive biological agents (SSBAs) that can be used both for good and for harm. This is known as ‘dual-use’. Exporting these SSBAs is monitored.

This fact sheet outlines the National Health Security (NHS) checks conducted under the SSBA Standards. It covers the need for NHS checks, applying for NHS checks, timeframes and provisional arrangements.

This fact sheet explains what to do if an SSBA has to be moved outside of the secure perimeter. This may happen in an emergency situation, such as a freezer malfunction, or if emergency maintenance is required.

This fact sheet provides information about the 2013 changes to the National Health Security Act 2007, the National Health Security Regulations 2008 and the SSBA Standards.

The Climate and Health Expert Advisory Group met on 12 December 2025. This document provides a record of the meeting.

This document contains the NAMAC Charter.

This Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This document contains our procedures for facilitating and dealing with public interest disclosures relating to the Australian Centre for Disease Control.

This document contains the surveillance case definition for leptospirosis, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

This document contains the surveillance case definition for hepatitis A, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

Our privacy policy sets out how we comply with the Privacy Act 1988.

This document outlines how we handle your personal information if you make a public interest disclosure.

This plan outlines the processes we follow and the steps involved in managing our information and making it available online.

This report covers data captured in the National Registry between 22 May 2024 and 30 June 2025.

This document contains the surveillance case definition for chlamydial infection, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

These guidelines describe recommended public health responses to cases and contacts of mpox. The Communicable Diseases Network Australia (CDNA) will continue to review these guidelines as more information becomes available.

Guidelines for health professionals that outline the therapeutic options for the management of mpox and vaccine related complications.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for melioidosis.

The National Syphilis Surveillance Reports are part of a collection that report progress against the National Syphilis Surveillance and Monitoring Plan 2025.

This report and accompanying table provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 10 to 23 November 2025.